Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS)

CNY 19.25

(-3.12%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.06 Billion 2.31 Billion 1.76 Billion 1.52 Billion 1.08 Billion 1.09 Billion
Total Current Assets 1.44 Billion 1.24 Billion 1.08 Billion 959.63 Million 546.27 Million 571.22 Million
Cash And Short Term Investments 522.68 Million 480.36 Million 487.68 Million 345.87 Million 154.08 Million 181.46 Million
Cash and Cash Equivalents 522.68 Million 480.36 Million 487.68 Million 345.87 Million 154.08 Million 181.46 Million
Short Term Investments - - - 5 Million - -
Net Receivables 590.13 Million 527.12 Million 371.54 Million 423.97 Million 240.47 Million 216.79 Million
Inventory 265.56 Million 213.56 Million 213.22 Million 185.99 Million 150.87 Million 168.87 Million
Other Current Assets 32.37 Million 26.2 Million 14.37 Million 3.79 Million 833.37 Thousand 4.09 Million
Total Non-Current Assets 1.61 Billion 1.06 Billion 674.1 Million 561.52 Million 540.33 Million 520.75 Million
Net PPE 1.26 Billion 802.61 Million 529.35 Million 416.78 Million 415.94 Million 426.82 Million
Good Will And Intangible Assets 267.56 Million 156.66 Million 135.61 Million 128.95 Million 82.67 Million 92.12 Million
Good Will 12.1 Million - - - - -
Intangible Assets 255.45 Million 156.66 Million 135.61 Million 128.95 Million 82.67 Million 92.12 Million
Long-Term Investments 20.44 Million 20.09 Million - 1.00 967.51 Thousand -
Tax Assets 9.54 Million 5.09 Million 8.12 Million 15.07 Million 1.46 Million 908.06 Thousand
Other Non Current Assets 57.18 Million 80.32 Million 1 Million 707.31 Thousand 39.27 Million 903.36 Thousand
Other Assets 0.00 1.00 1.00 1.00 - 1.00
Total Liabilities 1.9 Billion 1.29 Billion 830.4 Million 604.68 Million 442.67 Million 487.37 Million
Total Current Liabilities 1.08 Billion 1.05 Billion 793.94 Million 544.52 Million 398.84 Million 396.7 Million
Account Payables 194.16 Million 139.91 Million 149.12 Million 154.92 Million 147.67 Million 183.47 Million
Tax Payables 37.49 Million 24.73 Million 28.47 Million 20.22 Million 32.67 Million 21.3 Million
Short Term Debt 542.11 Million 505.57 Million 495.11 Million 230.97 Million 136.12 Million 111.57 Million
Deferred Revenue 330.54 Million 262.17 Million 141.12 Million 147.82 Million 74.03 Million 21.3 Million
Other Current Liabilities 15.67 Million 149.21 Million 8.58 Million 10.8 Million 41.02 Million 80.35 Million
Total Non Current Liabilities 818.67 Million 239.9 Million 36.46 Million 60.15 Million 43.82 Million 90.66 Million
Long-Term Debt 739.49 Million 178.4 Million 4.1 Million 52.04 Million 16.5 Million 30.52 Million
Deferred Revenue Non Current 76.22 Million 61.49 Million 32.35 Million 8.11 Million 9.65 Million 11.2 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.00 -177.61 Million 32.35 Million - 17.66 Million 48.93 Million
Other Liabilities 1.00 - 1.00 1.00 1.00 -
Total Equity 1.15 Billion 1.01 Billion 930.52 Million 916.47 Million 643.93 Million 604.6 Million
Stock Holders Equity 1.12 Billion 1.01 Billion 928.2 Million 916.47 Million 643.93 Million 604.6 Million
Common Stock 400.1 Million 400.1 Million 400.1 Million 400.1 Million 360 Million 360 Million
Retained Earnings 365.09 Million 265.47 Million 187.33 Million 181.85 Million 78.06 Million 50.42 Million
Accumulated other comprehensive income 64.61 Million 57.73 Million 50.19 Million 43.94 Million 52.48 Million 194.17 Million
Common Stock Equity 1.12 Billion 1.01 Billion 928.2 Million 916.47 Million 643.93 Million 604.6 Million
Capital Lease Obligation 2.07 Million 792.29 Thousand 4.1 Million 554.47 Thousand 17.66 Million 45.27 Million
Total Investments 20.44 Million 20.09 Million - 5 Million 967.51 Thousand -
Total Debt 1.28 Billion 683.98 Million 499.21 Million 283.01 Million 152.62 Million 142.09 Million
Net Debt 758.92 Million 203.61 Million 11.53 Million -62.85 Million -1.46 Million -39.36 Million

Balance Sheet Charts